Epidemiology of genital human papillomavirus infection.

A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis (2004) 2.70

Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog (2006) 2.65

Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer (2002) 2.25

Circumcision and STD in the United States: cross sectional and cohort analyses. Sex Transm Infect (2000) 1.94

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years. Hum Vaccin (2011) 1.73

Oncogenic activities of human papillomaviruses. Virus Res (2009) 1.60

Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine (2010) 1.53

HPV - immune response to infection and vaccination. Infect Agent Cancer (2010) 1.48

Genital warts: a comprehensive review. J Clin Aesthet Dermatol (2012) 1.40

Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis (2012) 1.38

Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol (2005) 1.37

Anal HPV infection in HIV-positive men who have sex with men from China. PLoS One (2010) 1.37

The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa. BMC Infect Dis (2007) 1.36

Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis (2009) 1.35

Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol (2006) 1.33

Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study. BMC Infect Dis (2008) 1.20

Genital HPV infection and related lesions in men. Prev Med (2011) 1.19

The influence of alcohol expectancies and intoxication on men's aggressive unprotected sexual intentions. Exp Clin Psychopharmacol (2010) 1.19

Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Br J Cancer (2005) 1.18

Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev (2008) 1.18

Coverage of Jade Goody's cervical cancer in UK newspapers: a missed opportunity for health promotion? BMC Public Health (2010) 1.15

Clinical trials of human papillomavirus vaccines and beyond. Nat Rev Clin Oncol (2013) 1.11

Sexually transmitted diseases among adults who had been abused and neglected as children: a 30-year prospective study. Am J Public Health (2009) 1.08

Barriers to cervical cancer screening among lesbians. J Womens Health (Larchmt) (2010) 1.08

Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions. Int J Cancer (2008) 1.06

Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study. J Infect Dis (2011) 1.05

Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review. Infect Agent Cancer (2011) 1.03

Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful. J Transl Med (2009) 1.03

Racial disparities in awareness of the human papillomavirus. J Womens Health (Larchmt) (2011) 1.02

The moral justification for a compulsory human papillomavirus vaccination program. Am J Public Health (2009) 1.02

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial. J Transl Med (2013) 1.02

Mechanism of human papillomavirus binding to human spermatozoa and fertilizing ability of infected spermatozoa. PLoS One (2011) 1.01

Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression. J Virol (2001) 1.00

Evidence for vertical transmission of HPV from mothers to infants. Infect Dis Obstet Gynecol (2010) 1.00

[HPV-associated alterations of the vulva and vagina. Morphology and molecular pathology]. Pathologe (2011) 1.00

Identification of a better Homo sapiens Class II HDAC inhibitor through binding energy calculations and descriptor analysis. BMC Bioinformatics (2010) 0.99

Ubiquitin-fused and/or multiple early genes from cottontail rabbit papillomavirus as DNA vaccines. J Virol (2002) 0.99

E2 proteins of high risk human papillomaviruses down-modulate STING and IFN-κ transcription in keratinocytes. PLoS One (2014) 0.99

Factors associated with intention to vaccinate a daughter against HPV: a statewide survey in Alabama. J Pediatr Adolesc Gynecol (2011) 0.98

Risk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with men. J Infect Dis (2013) 0.97

Awareness and knowledge about human papillomavirus among Latina immigrants. Ethn Dis (2010) 0.96

Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer. J Clin Pathol (2003) 0.96

A surgical approach to giant condyloma (Buschke-Löwenstein tumour) with underlying superficial vulvar carcinoma: A case report. Oncol Lett (2012) 0.95

Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis. PLoS One (2011) 0.95

Inhibition of gamma secretase blocks HPV infection. Virology (2010) 0.94

Adsorption of human papillomavirus 16 to live human sperm. PLoS One (2009) 0.93

The increasing frequency of cervical cancer in Korean women under 35. Cancer Res Treat (2008) 0.93

Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study. Br J Cancer (2008) 0.92

The management of anogenital [correction of anal] warts. BMJ (2000) 0.91

The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system. Open Virol J (2012) 0.91

Prevalence of abnormal cervical cytology among subfertile Saudi women. Ann Saudi Med (2010) 0.91

Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors. PLoS One (2011) 0.91

Analysis of CD4(+) T-cell responses to human papillomavirus (HPV) type 11 L1 in healthy adults reveals a high degree of responsiveness and cross-reactivity with other HPV types. J Virol (2002) 0.90

The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression. EMBO Mol Med (2015) 0.90

Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach. Open Virol J (2012) 0.89

The viral etiology of AIDS-associated malignancies. Adv Pharmacol (2008) 0.89

Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK. BMC Public Health (2013) 0.89

The impact of human papillomavirus information on perceived risk of cervical cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.88

Exposure to high-risk genital human papillomavirus and its association with risky sexual practices and laboratory-confirmed chlamydia among African-American women. Womens Health Issues (2009) 0.86

A prospective, open, comparative study of 5% potassium hydroxide solution versus cryotherapy in the treatment of genital warts in men. An Bras Dermatol (2014) 0.86

HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J Virol (2003) 0.85

Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women. BMC Womens Health (2015) 0.85

Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities. Infect Agent Cancer (2016) 0.84

Prevalence of HPV High-Risk Genotypes in Three Cohorts of Women in Ouagadougou (Burkina Faso). Mediterr J Hematol Infect Dis (2013) 0.84

Knowledge of human papillomavirus: differences by self-reported treatment for genital warts and sociodemographic characteristics. J Health Commun (2009) 0.84

Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV. J Immunol Res (2015) 0.84

Immunologic Control of Mus musculus Papillomavirus Type 1. PLoS Pathog (2015) 0.83

When do sexual partnerships need to be accounted for in transmission models of human papillomavirus? Int J Environ Res Public Health (2010) 0.83

Prevalence and predictors of high-risk human papillomavirus infection in a population-based sample of women in rural Uganda. Int J STD AIDS (2008) 0.83

Coexisting high-grade vulvar intraepithelial neoplasia (VIN) and condyloma acuminatum: independent lesions due to different HPV types occurring in immunocompromised patients. Am J Surg Pathol (2013) 0.82

Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia. BMC Infect Dis (2010) 0.82

Human papillomavirus, condylomata acuminata, and anal neoplasia. Clin Colon Rectal Surg (2004) 0.82

Understanding Public Perceptions of the HPV Vaccination Based on Online Comments to Canadian News Articles. PLoS One (2015) 0.82

The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors. Vaccine (2007) 0.82

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases. Hum Vaccin Immunother (2016) 0.82

Increasing girls' knowledge about human papillomavirus vaccination with a pre-test and a national leaflet: a quasi-experimental study. BMC Public Health (2013) 0.81

A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil). Ther Clin Risk Manag (2008) 0.81

Knowledge about HPV, relation between HPV and cervix cancer and acceptance of HPV vaccine in women in eastern region of Turkey. J Gynecol Oncol (2013) 0.81

MSMB gene variant alters the association between prostate cancer and number of sexual partners. Prostate (2013) 0.81

Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic viruses. FEBS Lett (2011) 0.81

Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands. BMC Public Health (2014) 0.81

Incidence of genital warts among the Hong Kong general adult population. BMC Infect Dis (2010) 0.80

Role and uptake of human papillomavirus vaccine in adolescent health in the United States. Adolesc Health Med Ther (2011) 0.80

Giant Condyloma Acuminatum of Vulva Frustrating Treatment Challenge. World J Plast Surg (2015) 0.80

HPV vaccine acceptance, utilization and expected impacts in the U.S.: Where are we now? Hum Vaccin (2010) 0.79

Status of Human Papillomavirus Infection in the Ethnic Population in Yunnan Province, China. Biomed Res Int (2015) 0.79

Recent advances in the search for antiviral agents against human papillomaviruses. Antivir Ther (2007) 0.79

Epidemiologic characterization of human papillomavirus (HPV) infection in various regions of Yunnan Province of China. BMC Infect Dis (2016) 0.79

Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening. Br J Cancer (2015) 0.78

Oestrogen receptor transcripts associated with cervical human papillomavirus infection. Sex Transm Infect (2002) 0.78

Impact of Widespread Cervical Cancer Screening: Number of Cancers Prevented and Changes in Race-specific Incidence. Am J Clin Oncol (2016) 0.78

Extralaryngeal HPV infections in male patients with adult-onset laryngeal papillomatosis. Eur Arch Otorhinolaryngol (2005) 0.78

Prognostic significance of histone methyltransferase enhancer of zeste homolog 2 in patients with cervical squamous cell carcinoma. Oncol Lett (2015) 0.77

Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia. PLoS One (2016) 0.77

[Molecular pathogenesis of cervical cancer and its first steps]. Pathologe (2005) 0.77

[Precancerous lesions of the uterine cervix: morphology and molecular pathology]. Pathologe (2011) 0.77

Novel antivirals inhibit early steps in HPV infection. Antiviral Res (2011) 0.77

Impact of New Sexually Transmitted Disease Diagnostics on Clinical Practice and Public Health Policy. Curr Infect Dis Rep (2001) 0.77

Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies. Infect Dis Obstet Gynecol (2011) 0.77

Local risk factors in genital human papilloma virus infection in cervical smears. Ann Med Health Sci Res (2013) 0.77